{
  "created_at": "Sat Jul 24 8:17:12 +0000 2021",
  "id_str": "1418730193464827910",
  "full_text": "In the race to develop shots against Covid-19, mRNA vaccines beat out many traditional approaches. Now, the technology is squaring up to an old viral nemesis: influenza. https://t.co/9R26GL6UCy",
  "display_text_range": [
    0,
    193
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/9R26GL6UCy",
        "expanded_url": "https://on.wsj.com/3kKW07t",
        "display_url": "on.wsj.com/3kKW07t",
        "indices": [
          170,
          193
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 36,
  "favorite_count": 79,
  "possibly_sensitive": false,
  "original_created_at": "Sat Jul 24 00:30:11 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "Covid-19に対する予防注射の開発競争では、mRNAワクチンが従来の多くのアプローチを凌駕しました。現在、この技術は、古くからのウイルスの宿敵であるインフルエンザに立ち向かっています。https://t.co/9R26GL6UCy"
    },
    {
      "locale": "zh",
      "full_text": "在开发针对Covid-19的疫苗的竞赛中，mRNA疫苗击败了许多传统方法。现在，这项技术正与一个古老的病毒克星--流感相抗衡。 https://t.co/9R26GL6UCy"
    },
    {
      "locale": "zh-Hant",
      "full_text": "在開發針對Covid-19的疫苗的競賽中，mRNA疫苗擊敗了許多傳統方法。現在，這項技術正與一個古老的病毒剋星--流感相抗衡。 https://t.co/9R26GL6UCy"
    }
  ]
}